Vinckenbosch, F., Theunissen, E., Stelling, A., Goldenbeld, C., & Ramaekers, J. G. (2024). Recreational Nitrous Oxide Dosing and Administration and Its Use in Traffic: An Online Survey. Journal of Drug Issues. Advance online publication. https://doi.org/10.1177/00220426241233193
Prevete, E., Catalani, V., Singh, D., Kuypers, K. P. C., Theunissen, E. L., Townshend, H. D., Banayoti, H., Ramaekers, J. G., Pasquini, M., & Corazza, O. (2023). A Preliminary Inventory of Kratom (Mitragyna Speciosa) Products and Vendors on the Darknet and Cryptomarkets. Journal of Psychoactive Drugs. Advance online publication. https://doi.org/10.1080/02791072.2023.2242361
Mallaroni, P., Mason, N. L., Reckweg, J. T., Paci, R., Ritscher, S., Toennes, S. W., Theunissen, E. L., Kuypers, K. P. C., & Ramaekers, J. G. (2023). Assessment of the Acute Effects of 2C-B vs. Psilocybin on Subjective Experience, Mood, and Cognition. Clinical Pharmacology & Therapeutics, 114(2), 423-433. https://doi.org/10.1002/cpt.2958
Reckweg, J. T., van Leeuwen, C. J., Henquet, C., van Amelsvoort, T., Theunissen, E. L., Mason, N. L., Paci, R., Terwey, T. H., & Ramaekers, J. G. (2023). A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression. Frontiers in Psychiatry, 14, Article 1133414. https://doi.org/10.3389/fpsyt.2023.1133414
Prevete, E., Kuypers, K. P. C., Theunissen, E. L., Esposito, G., Ramaekers, J. G., Pasquini, M., & Corazza, O. (2023). Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review. Current Addiction Reports, 10(2), 317-334. https://doi.org/10.1007/s40429-023-00478-3
Hutten, N. R. P. W., Arkell, T. R., Vinckenbosch, F., Schepers, J., Kevin, R. C., Theunissen, E. L., Kuypers, K. P. C., McGregor, I. S., & Ramaekers, J. G. (2022). Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis. Psychopharmacology, 239(11), 3731-3741. https://doi.org/10.1007/s00213-022-06248-9
Theunissen, E. L., Kuypers, K. P. C., Mason, N. L., & Ramaekers, J. G. (2022). A Comparison of Acute Neurocognitive and Psychotomimetic Effects of a Synthetic Cannabinoid and Natural Cannabis at Psychotropic Dose Equivalence. Frontiers in Psychiatry, 13, Article 891811. https://doi.org/10.3389/fpsyt.2022.891811
Theunissen, E. L., Reckweg, J. T., Hutten, N. R. P. W., Kuypers, K. P. C., Toennes, S. W., Neukamm, M. A., Halter, S., & Ramaekers, J. G. (2022). Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis. Psychopharmacology, 239(5), 1251-1261. https://doi.org/10.1007/s00213-021-05768-0
Ramaekers, J. G., Theunissen, E. L., van Ruitenbeek, P., & Mason, N. L. (2022). Cannabis Use and Neuroadaptation: A Call for Δ 9 -Tetrahydrocannabinol Challenge Studies. Frontiers in Psychiatry, 13, 1-7. Article 870750. https://doi.org/10.3389/fpsyt.2022.870750
Arkell, T. R., Kevin, R. C., Vinckenbosch, F., Lintzeris, N., Theunissen, E., Ramaekers, J. G., & McGregor, I. S. (2022). Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials. Addiction Biology, 27(2), Article e13125. https://doi.org/10.1111/adb.13125
